Myriad Genetics | 8-K: Myriad Genetics Reports Strong Second Quarter 2024 Financial Results, including 15% Revenue Growth Year-Over-Year; Raises 2024 Financial Guidance and Long-Term Revenue Growth Target to 12%
Myriad Genetics | 8-K: Myriad Genetics Reports Strong Second Quarter 2024 Financial Results, including 15% Revenue Growth Year-Over-Year; Raises 2024 Financial Guidance and Long-Term Revenue Growth Target to 12%
萬基遺傳 | 8-K:Myriad Genetics公佈了強勁的2024年第二季度財務業績,包括收入同比增長15%;將2024年的財務指導和長期收入增長目標提高至12%